Healthcare Sector Stocks
The Healthcare sector has a total of 1045 stocks, with a combined market cap of $9.24 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.83.
Market Cap
9.24T
Revenue
4.67T
Profits
189.21B
PE Ratio
48.83
Profit Margin
4.06%
Dividend Yield
0.38%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | 1.28% | 1,898,211 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 651.20B | 1.10% | 6,570,575 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 466.55B | 0.58% | 3,509,772 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 363.04B | 1.55% | 11,063,650 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 336.79B | -0.01% | 4,837,673 | 450.53B |
| 6 | NVS | Novartis AG | 267.51B | 1.60% | 1,713,977 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 257.37B | 2.00% | 3,807,670 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 243.41B | 1.53% | 4,199,983 | 46.34B |
| 9 | AMGN | Amgen Inc. | 205.32B | 0.91% | 3,234,924 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 189.74B | 3.55% | 12,979,347 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 187.10B | 2.17% | 7,943,364 | 30.46B |
| 12 | ABT | Abbott Laboratories | 176.90B | -0.13% | 8,425,926 | 46.59B |
| 13 | PFE | Pfizer Inc. | 157.54B | 0.66% | 29,012,316 | 63.70B |
| 14 | DHR | Danaher Corporation | 149.38B | 1.99% | 6,179,160 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 135.50B | 0.33% | 2,393,622 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 130.87B | 0.60% | 899,706 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 128.36B | -1.19% | 12,212,808 | 49.19B |
| 18 | MDT | Medtronic plc | 118.67B | 0.18% | 10,900,891 | 37.54B |
| 19 | CVS | CVS Health Corporation | 115.45B | -1.58% | 7,434,655 | 412.65B |
| 20 | SYK | Stryker Corporation | 107.45B | -1.63% | 2,367,779 | 25.84B |
| 21 | SNY | Sanofi | 103.52B | 1.29% | 2,955,709 | 55.89B |
| 22 | MCK | McKesson Corporation | 102.55B | -0.87% | 577,236 | 410.98B |
| 23 | GSK | GSK plc | 101.65B | 1.53% | 3,075,202 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.89B | -0.32% | 1,188,076 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 89.84B | 0.41% | 1,189,839 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.83B | 1.92% | 702,761 | 15.53B |
| 27 | CI | The Cigna Group | 72.93B | -1.59% | 1,174,459 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 63.11B | -0.82% | 32,569,725 | 21.00B |
| 29 | MRNA | Moderna, Inc. | 63.11B | 8.55% | 19,243,615 | 2.23B |
| 30 | ARGX | argenx SE | 62.32B | 1.13% | 245,901 | 5.32B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.94B | 2.20% | 2,710,686 | 28.42B |
| 32 | COR | Cencora, Inc. | 59.04B | -2.85% | 1,098,490 | 332.77B |
| 33 | NTRA | Natera, Inc. | 52.80B | 6.07% | 2,560,729 | 2.71B |
| 34 | CAH | Cardinal Health, Inc. | 52.64B | -2.67% | 2,260,541 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 50.87B | -1.15% | 3,880,108 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 49.41B | -0.26% | 1,839,770 | 22.48B |
| 37 | HUM | Humana Inc. | 46.17B | -0.05% | 850,185 | 145.68B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 45.67B | 1.71% | 5,521,446 | 17.32B |
| 39 | IQV | IQVIA Holdings Inc. | 44.35B | 0.23% | 1,714,582 | 16.98B |
| 40 | A | Agilent Technologies, Inc. | 44.08B | 1.72% | 2,893,909 | 7.37B |
| 41 | VEEV | Veeva Systems Inc. | 42.70B | -0.43% | 1,120,754 | 3.46B |
| 42 | MDLN | Medline Inc. | 42.23B | -2.64% | 8,687,934 | 29.94B |
| 43 | WAT | Waters Corporation | 42.22B | 2.65% | 688,819 | 4.64B |
| 44 | RVMD | Revolution Medicines, Inc. | 42.21B | 0.52% | 1,821,066 | - |
| 45 | ONC | BeOne Medicines AG | 40.19B | 1.55% | 285,994 | 6.13B |
| 46 | HLN | Haleon plc | 39.95B | 1.63% | 39,649,991 | 14.80B |
| 47 | IDXX | IDEXX Laboratories, Inc. | 39.90B | -1.39% | 459,824 | 4.55B |
| 48 | ILMN | Illumina, Inc. | 37.02B | 7.10% | 3,676,675 | 4.49B |
| 49 | RPRX | Royalty Pharma plc | 33.88B | 0.79% | 2,062,507 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 33.18B | 0.68% | 2,823,965 | 4.97B |
| 51 | CNC | Centene Corporation | 33.15B | 1.65% | 5,133,625 | 180.30B |
| 52 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.85B | 2.57% | 968,924 | 4.80B |
| 53 | RMD | ResMed Inc. | 32.68B | 0.07% | 1,085,527 | 5.65B |
| 54 | BIIB | Biogen Inc. | 32.37B | 1.41% | 836,657 | 10.03B |
| 55 | ALC | Alcon Inc. | 31.34B | -1.69% | 2,136,319 | 10.86B |
| 56 | ZTS | Zoetis Inc. | 30.17B | 0.03% | 4,043,779 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 29.11B | 1.50% | 4,486,607 | 21.27B |
| 58 | ROIV | Roivant Sciences Ltd. | 28.88B | 1.04% | 7,603,968 | 7.53M |
| 59 | MTD | Mettler-Toledo International Inc. | 28.26B | 2.30% | 288,010 | 4.13B |
| 60 | DGX | Quest Diagnostics Incorporated | 27.31B | 0.15% | 989,490 | 11.56B |
| 61 | INSM | Insmed Incorporated | 27.07B | 1.14% | 1,592,256 | 1.14B |
| 62 | LH | Labcorp Holdings Inc. | 26.17B | -0.55% | 559,872 | 14.35B |
| 63 | INCY | Incyte Corporation | 25.87B | 2.30% | 1,452,797 | 5.82B |
| 64 | WST | West Pharmaceutical Services, Inc. | 25.80B | 1.27% | 474,005 | 3.33B |
| 65 | BNTX | BioNTech SE | 24.78B | 2.95% | 707,961 | 3.03B |
| 66 | GH | Guardant Health, Inc. | 24.57B | 4.69% | 1,858,422 | 1.18B |
| 67 | PHG | Koninklijke Philips N.V. | 24.17B | -0.20% | 1,057,404 | 20.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.33B | -0.24% | 1,454,410 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.09B | -1.46% | 706,381 | 21.81B |
| 70 | GMAB | Genmab A/S | 20.59B | 0.39% | 2,703,019 | 4.13B |
| 71 | STE | STERIS plc | 20.28B | -0.89% | 765,548 | 6.04B |
| 72 | VTRS | Viatris Inc. | 19.68B | 0.65% | 7,018,573 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.98B | -2.61% | 2,203,813 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.17B | -0.20% | 226,107 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 16.37B | 0.69% | 2,753,779 | 2.91B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.83B | 0.10% | 569,585 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 15.70B | -3.49% | 1,060,373 | 1.20B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.43B | 1.56% | 1,178,094 | 3.37B |
| 79 | SOLV | Solventum Corporation | 14.90B | -1.46% | 1,042,830 | 8.31B |
| 80 | TEM | Tempus AI, Inc. | 14.50B | 14.85% | 17,128,001 | 1.43B |
| 81 | EXEL | Exelixis, Inc. | 14.49B | 3.01% | 1,687,967 | 2.44B |
| 82 | SMMT | Summit Therapeutics Inc. | 14.14B | 2.43% | 6,134,930 | - |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.45B | 3.02% | 809,837 | 4.00B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.16B | -1.45% | 2,334,288 | 713.07M |
| 85 | ICLR | ICON Public Limited Company | 13.09B | -2.45% | 1,172,012 | 8.29B |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 12.60B | 0.54% | 1,380,832 | 3.41B |
| 87 | PEN | Penumbra, Inc. | 12.56B | 0.15% | 416,074 | 1.50B |
| 88 | HALO | Halozyme Therapeutics, Inc. | 12.45B | 1.14% | 1,967,574 | 1.66B |
| 89 | CORT | Corcept Therapeutics Incorporated | 12.42B | 2.73% | 861,601 | 830.81M |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.35B | 1.00% | 153,300 | 1.28B |
| 91 | EHC | Encompass Health Corporation | 12.15B | -0.62% | 751,703 | 6.21B |
| 92 | BAX | Baxter International Inc. | 11.90B | -2.17% | 6,614,973 | 11.47B |
| 93 | FMS | Fresenius Medical Care AG | 11.87B | -3.92% | 1,251,258 | 22.19B |
| 94 | BTSG | BrightSpring Health Services, Inc. | 11.79B | -4.00% | 2,452,917 | 14.37B |
| 95 | DVA | DaVita Inc. | 11.68B | -5.56% | 1,411,188 | 14.01B |
| 96 | SNN | Smith & Nephew plc | 11.63B | -0.07% | 1,169,809 | 6.30B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.36B | -0.52% | 4,609,676 | 5.02B |
| 98 | TECH | Bio-Techne Corporation | 11.36B | 0.11% | 3,762,201 | 1.22B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 11.22B | 1.09% | 681,362 | 776.57M |
| 100 | AVTR | Avantor, Inc. | 10.73B | 1.60% | 9,832,713 | 6.56B |
| 101 | MOH | Molina Healthcare, Inc. | 10.68B | 1.42% | 508,746 | 42.47B |
| 102 | UHS | Universal Health Services, Inc. | 10.65B | -0.25% | 1,050,106 | 18.11B |
| 103 | ALGN | Align Technology, Inc. | 10.64B | -0.49% | 787,518 | 4.14B |
| 104 | COO | The Cooper Companies, Inc. | 10.23B | -1.53% | 5,713,350 | 4.24B |
| 105 | BIO | Bio-Rad Laboratories, Inc. | 10.22B | 0.89% | 204,956 | 2.59B |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.19B | 4.37% | 3,750,087 | 3.50B |
| 107 | ENSG | The Ensign Group, Inc. | 10.11B | -1.65% | 405,885 | 5.49B |
| 108 | RGEN | Repligen Corporation | 10.06B | 3.05% | 1,087,042 | 785.10M |
| 109 | TXG | 10x Genomics, Inc. | 10.03B | 5.90% | 3,142,935 | 616.91M |
| 110 | KRYS | Krystal Biotech, Inc. | 10.03B | 0.62% | 280,926 | 440.48M |
| 111 | GMED | Globus Medical, Inc. | 9.96B | -1.46% | 1,424,342 | 3.14B |
| 112 | OSCR | Oscar Health, Inc. | 9.86B | -1.11% | 5,595,941 | 15.32B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.85B | 1.85% | 570,486 | 105.00M |
| 114 | PODD | Insulet Corporation | 9.82B | 0.68% | 1,197,252 | 3.05B |
| 115 | TWST | Twist Bioscience Corporation | 9.75B | 8.73% | 3,370,681 | 431.80M |
| 116 | CYTK | Cytokinetics, Incorporated | 9.72B | 0.76% | 1,398,170 | 67.67M |
| 117 | BRKR | Bruker Corporation | 9.61B | 3.92% | 3,075,049 | 3.50B |
| 118 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.57B | 2.96% | 3,181,843 | 669.50M |
| 119 | GKOS | Glaukos Corporation | 9.52B | -1.25% | 646,793 | 612.84M |
| 120 | HSIC | Henry Schein, Inc. | 9.48B | -1.99% | 1,764,053 | 13.60B |
| 121 | ABVX | ABIVAX Société Anonyme | 9.38B | 4.66% | 1,151,903 | 5.67M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 9.30B | 0.60% | 558,898 | 281.99M |
| 123 | QGEN | Qiagen N.V. | 9.18B | 3.45% | 1,906,809 | 2.10B |
| 124 | PCVX | Vaxcyte, Inc. | 8.98B | 2.72% | 1,309,150 | - |
| 125 | IBRX | ImmunityBio, Inc. | 8.97B | 6.95% | 19,159,326 | 165.79M |
| 126 | CAI | Caris Life Sciences, Inc. | 8.74B | 9.61% | 7,661,747 | 989.61M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 8.67B | 0.48% | 555,919 | 7.46M |
| 128 | SYRE | Spyre Therapeutics, Inc. | 8.17B | 1.66% | 1,438,884 | - |
| 129 | TGTX | TG Therapeutics, Inc. | 8.01B | 1.11% | 1,467,854 | 799.54M |
| 130 | ATR | AptarGroup, Inc. | 7.98B | 0.63% | 551,463 | 3.93B |
| 131 | ALKS | Alkermes plc | 7.84B | 1.39% | 1,400,932 | 1.67B |
| 132 | HQY | HealthEquity, Inc. | 7.82B | -1.55% | 638,085 | 1.36B |
| 133 | IMVT | Immunovant, Inc. | 7.78B | 3.49% | 1,330,615 | - |
| 134 | IONS | Ionis Pharmaceuticals, Inc. | 7.77B | 4.26% | 4,079,568 | 874.09M |
| 135 | HNGE | Hinge Health, Inc. | 7.64B | 1.06% | 2,060,780 | 720.06M |
| 136 | BLTE | Belite Bio, Inc | 6.86B | 0.67% | 136,024 | - |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.82B | 1.03% | 617,730 | 239.92M |
| 138 | CGON | CG Oncology, Inc. | 6.70B | 2.02% | 894,291 | 6.23M |
| 139 | PACS | PACS Group, Inc. | 6.66B | -1.54% | 707,062 | 5.55B |
| 140 | GRFS | Grifols, S.A. | 6.63B | - | 244,539 | 8.48B |
| 141 | CHE | Chemed Corporation | 6.59B | -0.77% | 144,663 | 2.60B |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.58B | 0.26% | 569,024 | 1.56B |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.51B | -0.39% | 8,242,988 | 2.58B |
| 144 | ORKA | Oruka Therapeutics, Inc. | 6.47B | 4.47% | 1,046,949 | - |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 6.42B | 1.49% | 926,224 | 618.07M |
| 146 | AMRX | Amneal Pharmaceuticals, Inc. | 6.37B | 1.11% | 2,816,756 | 3.12B |
| 147 | MMED | MiniMed Group, Inc. | 6.20B | -1.65% | 2,830,478 | 3.22B |
| 148 | STVN | Stevanato Group S.p.A. | 6.19B | 0.62% | 507,118 | 1.40B |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.19B | 2.20% | 722,009 | 840.85M |
| 150 | LQDA | Liquidia Corporation | 6.12B | -0.09% | 1,082,256 | 450.91M |
| 151 | RDNT | RadNet, Inc. | 6.12B | 2.64% | 573,219 | 2.27B |
| 152 | TVTX | Travere Therapeutics, Inc. | 6.10B | 1.98% | 1,384,695 | 591.33M |
| 153 | BLCO | Bausch + Lomb Corporation | 5.99B | -1.76% | 478,476 | 5.32B |
| 154 | SRRK | Scholar Rock Holding Corporation | 5.97B | -0.71% | 3,485,702 | - |
| 155 | COGT | Cogent Biosciences, Inc. | 5.76B | 2.00% | 1,189,526 | - |
| 156 | LGND | Ligand Pharmaceuticals Incorporated | 5.68B | 3.45% | 248,805 | 290.54M |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.68B | 0.61% | 1,090,412 | 1.01B |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 5.66B | -1.34% | 1,140,557 | 1.90M |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.55B | 1.04% | 1,832,045 | 7.50M |
| 160 | CRSP | CRISPR Therapeutics AG | 5.54B | 9.80% | 3,000,241 | 13.39M |
| 161 | SHC | Sotera Health Company | 5.41B | -1.97% | 1,964,367 | 1.22B |
| 162 | ERAS | Erasca, Inc. | 5.37B | -0.13% | 7,548,639 | - |
| 163 | TFX | Teleflex Incorporated | 5.32B | -1.88% | 867,132 | 2.25B |
| 164 | BLLN | BillionToOne, Inc. | 5.22B | 6.81% | 547,229 | 397.41M |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.20B | 2.19% | 1,729,891 | - |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.11B | -0.66% | 319,366 | 1.58B |
| 167 | EWTX | Edgewise Therapeutics, Inc. | 5.10B | 3.30% | 2,407,771 | - |
| 168 | WAY | Waystar Holding Corp. | 5.08B | -0.30% | 1,730,761 | 1.21B |
| 169 | PBLS | Parabilis Medicines, Inc. | 5.05B | 10.85% | 1,093,176 | 148.00K |
| 170 | HAE | Haemonetics Corporation | 4.90B | 1.28% | 621,112 | 1.35B |
| 171 | LFST | LifeStance Health Group, Inc. | 4.82B | -1.41% | 7,351,330 | 1.58B |
| 172 | DOCS | Doximity, Inc. | 4.74B | 2.43% | 2,171,274 | 655.57M |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | 4.73B | -0.33% | 1,276,741 | 1.14B |
| 174 | ADPT | Adaptive Biotechnologies Corporation | 4.56B | 3.18% | 3,279,603 | 308.08M |
| 175 | MANE | Veradermics, Incorporated | 4.54B | 6.11% | 766,415 | - |
| 176 | IOVA | Iovance Biotherapeutics, Inc. | 4.54B | 1.52% | 24,203,890 | 324.97M |
| 177 | CON | Concentra Group Holdings Parent, Inc. | 4.53B | -2.31% | 1,117,604 | 2.29B |
| 178 | HTFL | HeartFlow, Inc. | 4.31B | 2.63% | 2,053,941 | 212.07M |
| 179 | ITGR | Integer Holdings Corporation | 4.29B | 0.17% | 715,699 | 1.84B |
| 180 | LIVN | LivaNova PLC | 4.29B | -0.92% | 627,278 | 1.47B |
| 181 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.26B | 4.01% | 1,506,499 | -665.00K |
| 182 | TLX | Telix Pharmaceuticals Limited | 4.22B | 5.71% | 412,912 | 890.79M |
| 183 | INDV | Indivior Pharmaceuticals, Inc. | 4.21B | 3.90% | 2,690,469 | 1.33B |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.21B | 1.86% | 3,095,724 | 10.35M |
| 185 | CELC | Celcuity Inc. | 4.15B | 2.82% | 692,108 | - |
| 186 | ABCL | AbCellera Biologics Inc. | 4.13B | 9.08% | 8,045,088 | 66.17M |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.96B | 0.60% | 1,721,938 | 53.81M |
| 188 | ICUI | ICU Medical, Inc. | 3.82B | -1.74% | 204,395 | 2.16B |
| 189 | NVST | Envista Holdings Corporation | 3.81B | -5.13% | 4,668,911 | 2.86B |
| 190 | IDYA | IDEAYA Biosciences, Inc. | 3.73B | 2.33% | 757,752 | 234.13M |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.68B | -0.19% | 365,438 | 825.34M |
| 192 | ELVN | Enliven Therapeutics, Inc. | 3.68B | 2.28% | 1,963,459 | - |
| 193 | OPCH | Option Care Health, Inc. | 3.67B | 0.12% | 3,810,267 | 5.69B |
| 194 | PLSE | Pulse Biosciences, Inc. | 3.61B | 2.02% | 571,882 | 1.19M |
| 195 | OGN | Organon & Co. | 3.60B | 0.15% | 1,263,463 | 6.13B |
| 196 | GRAL | GRAIL, Inc. | 3.57B | 6.44% | 1,529,324 | 165.26M |
| 197 | NHC | National HealthCare Corporation | 3.52B | -0.23% | 76,126 | 1.56B |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 3.47B | 1.79% | 474,857 | 606.33M |
| 199 | VKTX | Viking Therapeutics, Inc. | 3.42B | -0.54% | 2,086,630 | - |
| 200 | LEGN | Legend Biotech Corporation | 3.41B | 3.41% | 1,953,608 | 1.27B |
| 201 | DYN | Dyne Therapeutics, Inc. | 3.37B | 4.33% | 2,846,760 | - |
| 202 | ARQT | Arcutis Biotherapeutics, Inc. | 3.33B | 1.22% | 5,862,457 | 463.98M |
| 203 | VCYT | Veracyte, Inc. | 3.26B | 5.38% | 1,470,326 | 561.90M |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.25B | 3.61% | 2,010,957 | 117.00M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.22B | 0.35% | 1,421,472 | 3.60M |
| 206 | WGS | GeneDx Holdings Corp. | 3.13B | 7.73% | 827,130 | 454.43M |
| 207 | MBX | MBX Biosciences, Inc. | 3.08B | 3.77% | 969,810 | - |
| 208 | CLDX | Celldex Therapeutics, Inc. | 3.06B | 0.70% | 1,278,872 | 158.00K |
| 209 | QURE | uniQure N.V. | 3.06B | 3.77% | 798,694 | 18.67M |
| 210 | AVAH | Aveanna Healthcare Holdings Inc. | 3.05B | -2.03% | 3,277,895 | 2.60B |
| 211 | ATRC | AtriCure, Inc. | 3.01B | 3.47% | 1,539,560 | 569.62M |
| 212 | TMDX | TransMedics Group, Inc. | 3.00B | -1.03% | 690,550 | 668.47M |
| 213 | WRBY | Warby Parker Inc. | 2.99B | 2.68% | 2,125,594 | 911.61M |
| 214 | RGC | Regencell Bioscience Holdings Limited | 2.95B | 4.93% | 72,948 | - |
| 215 | ZLAB | Zai Lab Limited | 2.90B | 4.62% | 673,109 | 449.61M |
| 216 | GRDN | Guardian Pharmacy Services, Inc. | 2.85B | -3.16% | 604,027 | 1.46B |
| 217 | PGEN | Precigen, Inc. | 2.82B | 5.78% | 9,364,227 | 85.72M |
| 218 | CDNA | CareDx, Inc. | 2.81B | 1.36% | 806,701 | 458.09M |
| 219 | NEOG | Neogen Corporation | 2.80B | 2.23% | 3,582,436 | 870.40M |
| 220 | BKD | Brookdale Senior Living Inc. | 2.77B | -0.77% | 4,241,461 | 2.93B |
| 221 | IMNM | Immunome, Inc. | 2.72B | 2.00% | 890,742 | 4.02M |
| 222 | ACHC | Acadia Healthcare Company, Inc. | 2.68B | 2.31% | 1,546,027 | 3.37B |
| 223 | PHVS | Pharvaris N.V. | 2.67B | 1.20% | 1,137,444 | - |
| 224 | AXGN | Axogen, Inc. | 2.66B | -0.34% | 831,482 | 251.17M |
| 225 | IRON | Disc Medicine, Inc. | 2.66B | 0.89% | 621,690 | - |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.65B | 1.39% | 1,511,894 | 36.77M |
| 227 | NAMS | NewAmsterdam Pharma Company N.V. | 2.62B | 3.54% | 2,310,526 | 7.12M |
| 228 | PRVA | Privia Health Group, Inc. | 2.57B | -1.37% | 1,054,530 | 2.36B |
| 229 | NEO | NeoGenomics, Inc. | 2.56B | 5.02% | 2,006,839 | 766.30M |
| 230 | GPCR | Structure Therapeutics Inc. | 2.50B | -1.13% | 1,011,424 | - |
| 231 | SUPN | Supernus Pharmaceuticals, Inc. | 2.49B | 3.72% | 559,773 | 830.44M |
| 232 | HRMY | Harmony Biosciences Holdings, Inc. | 2.49B | 1.26% | 641,414 | 959.90M |
| 233 | VRDN | Viridian Therapeutics, Inc. | 2.48B | -2.32% | 1,268,415 | 71.13M |
| 234 | MLYS | Mineralys Therapeutics, Inc. | 2.47B | 1.60% | 1,141,567 | - |
| 235 | VERA | Vera Therapeutics, Inc. | 2.47B | 7.87% | 3,885,468 | - |
| 236 | BEAM | Beam Therapeutics Inc. | 2.47B | 6.80% | 2,429,235 | 156.04M |
| 237 | CLOV | Clover Health Investments, Corp. | 2.41B | -0.44% | 3,692,487 | 2.48B |
| 238 | HCM | HUTCHMED (China) Limited | 2.40B | 3.19% | 35,053 | 549.12M |
| 239 | NKTR | Nektar Therapeutics | 2.33B | 1.45% | 1,264,862 | 54.59M |
| 240 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | -1.11% | 4,811,865 | - |
| 241 | SDGR | Schrödinger, Inc. | 2.26B | 26.37% | 9,034,626 | 259.04M |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.26B | - | 850,171 | 311.51M |
| 243 | TRLV | Trulieve Cannabis Corp. | 2.24B | 0.87% | 1,570,719 | 1.14B |
| 244 | OCUL | Ocular Therapeutix, Inc. | 2.23B | 2.74% | 2,311,371 | 52.06M |
| 245 | PVLA | Palvella Therapeutics, Inc. | 2.22B | 1.91% | 157,921 | - |
| 246 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.22B | 3.20% | 5,220,505 | 940.61M |
| 247 | ALMR | Alamar Biosciences, Inc. | 2.22B | 8.95% | 551,823 | 100.42M |
| 248 | PBH | Prestige Consumer Healthcare Inc. | 2.20B | -0.83% | 504,030 | 1.10B |
| 249 | GENB | Generate Biomedicines, Inc. | 2.20B | 9.18% | 2,205,740 | 26.48M |
| 250 | SRPT | Sarepta Therapeutics, Inc. | 2.18B | 4.61% | 2,588,120 | 1.97B |
| 251 | TRVI | Trevi Therapeutics, Inc. | 2.17B | 1.33% | 1,500,736 | - |
| 252 | ADUS | Addus HomeCare Corporation | 2.16B | -0.38% | 216,917 | 1.48B |
| 253 | URGN | UroGen Pharma Ltd. | 2.15B | 1.06% | 699,362 | 188.73M |
| 254 | UFPT | UFP Technologies, Inc. | 2.13B | -1.43% | 86,891 | 631.64M |
| 255 | NUVB | Nuvation Bio Inc. | 2.13B | 5.02% | 5,738,782 | 169.90M |
| 256 | BFLY | Butterfly Network, Inc. | 2.12B | 9.64% | 5,936,521 | 112.14M |
| 257 | BHC | Bausch Health Companies Inc. | 2.11B | -0.70% | 2,865,488 | 10.85B |
| 258 | INSP | Inspire Medical Systems, Inc. | 2.10B | -0.01% | 564,174 | 898.74M |
| 259 | BHVN | Biohaven Ltd. | 2.10B | 15.56% | 5,833,554 | - |
| 260 | ZBIO | Zenas BioPharma, Inc. | 2.08B | -1.08% | 527,840 | 1.00M |
| 261 | CMPS | COMPASS Pathways plc | 2.08B | 8.70% | 4,967,783 | - |
| 262 | ESTA | Establishment Labs Holdings Inc. | 2.07B | -2.25% | 313,207 | 245.82M |
| 263 | PGNY | Progyny, Inc. | 2.07B | -1.35% | 828,688 | 1.31B |
| 264 | KOD | Kodiak Sciences Inc. | 2.06B | 0.24% | 826,147 | - |
| 265 | VCEL | Vericel Corporation | 2.05B | -0.45% | 536,418 | 306.30M |
| 266 | MD | Pediatrix Medical Group, Inc. | 2.02B | -2.45% | 856,546 | 1.95B |
| 267 | RAPP | Rapport Therapeutics, Inc. | 2.01B | 1.35% | 397,297 | 20.00M |
| 268 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | 2.00% | 868,567 | 98.34M |
| 269 | ADMA | ADMA Biologics, Inc. | 2.00B | 0.56% | 2,131,483 | 512.28M |
| 270 | GHRS | GH Research PLC | 1.97B | 3.50% | 501,549 | - |
| 271 | ZYME | Zymeworks Inc. | 1.95B | 4.73% | 1,330,336 | 37.13M |
| 272 | NVCR | NovoCure Limited | 1.95B | 3.08% | 1,482,998 | 699.19M |
| 273 | FTRE | Fortrea Holdings Inc. | 1.93B | 1.55% | 2,286,808 | 2.68B |
| 274 | COAG | Hemab Therapeutics Holdings, Inc. | 1.93B | 0.54% | 429,041 | - |
| 275 | ALVO | Alvotech | 1.91B | 4.71% | 1,705,978 | 494.61M |
| 276 | MESO | Mesoblast Limited | 1.90B | 3.19% | 143,527 | 120.25M |
| 277 | RXRX | Recursion Pharmaceuticals, Inc. | 1.90B | 10.97% | 28,251,171 | 54.86M |
| 278 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.89B | 6.29% | 3,447,946 | 208.78M |
| 279 | PRGO | Perrigo Company plc | 1.87B | -0.44% | 2,247,844 | 4.14B |
| 280 | XRAY | DENTSPLY SIRONA Inc. | 1.87B | -7.54% | 9,309,035 | 3.64B |
| 281 | STOK | Stoke Therapeutics, Inc. | 1.87B | 3.65% | 960,034 | 27.59M |
| 282 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 5.01% | 467,611 | 1.13B |
| 283 | VIR | Vir Biotechnology, Inc. | 1.85B | 3.80% | 1,794,364 | 303.23M |
| 284 | SEPN | Septerna, Inc. | 1.84B | 2.76% | 241,527 | 98.88M |
| 285 | SNDA | Sonida Senior Living, Inc. | 1.84B | -1.75% | 392,457 | 481.07M |
| 286 | XNCR | Xencor, Inc. | 1.83B | 3.71% | 1,026,901 | 104.97M |
| 287 | LMAT | LeMaitre Vascular, Inc. | 1.82B | -1.13% | 204,832 | 262.43M |
| 288 | ALHC | Alignment Healthcare, Inc. | 1.80B | -0.11% | 25,424,844 | 4.58B |
| 289 | BLFS | BioLife Solutions, Inc. | 1.80B | 2.05% | 1,571,310 | 106.69M |
| 290 | NBTX | Nanobiotix S.A. | 1.78B | 4.30% | 99,770 | 38.27M |
| 291 | BRVE | Braveheart Bio, Inc. | 1.78B | 0.95% | 577,364 | - |
| 292 | ASTH | Astrana Health, Inc. | 1.76B | -9.02% | 1,051,929 | 3.84B |
| 293 | FRNM | Freenome, Inc. | 1.75B | 10.59% | 1,135,978 | 35.41M |
| 294 | PSNL | Personalis, Inc. | 1.73B | 0.74% | 5,649,397 | 69.67M |
| 295 | SGRY | Surgery Partners, Inc. | 1.73B | -4.24% | 3,806,232 | 3.37B |
| 296 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 6.70% | 5,760,971 | 59.51M |
| 297 | TSHA | Taysha Gene Therapies, Inc. | 1.68B | 1.78% | 4,082,270 | 5.49M |
| 298 | TYRA | Tyra Biosciences, Inc. | 1.68B | 0.33% | 511,724 | - |
| 299 | KLRA | Kailera Therapeutics, Inc. | 1.67B | 1.73% | 1,036,226 | - |
| 300 | IMCR | Immunocore Holdings plc | 1.66B | 2.25% | 259,262 | 430.78M |
| 301 | NVAX | Novavax, Inc. | 1.65B | 6.95% | 8,876,132 | 413.80M |
| 302 | ETON | Eton Pharmaceuticals, Inc. | 1.63B | 1.28% | 314,097 | 105.60M |
| 303 | ANAB | AnaptysBio, Inc. | 1.63B | 1.38% | 439,570 | 232.39M |
| 304 | ANIP | ANI Pharmaceuticals, Inc. | 1.62B | 2.47% | 563,398 | 978.38M |
| 305 | ABSI | Absci Corporation | 1.59B | 15.30% | 8,665,817 | 1.56M |
| 306 | ATEC | Alphatec Holdings, Inc. | 1.59B | -2.10% | 2,756,547 | 815.05M |
| 307 | LTGO | Latigo Biotherapeutics, Inc. | 1.59B | 3.77% | 430,919 | - |
| 308 | SNDX | Syndax Pharmaceuticals, Inc. | 1.58B | 2.31% | 2,520,840 | 252.25M |
| 309 | KARD | Kardigan, Inc. | 1.56B | -3.58% | 710,229 | - |
| 310 | INBX | Inhibrx Biosciences, Inc. | 1.54B | 2.91% | 217,279 | 1.30M |
| 311 | KRSA | Korsana Biosciences, Inc. | 1.54B | 7.97% | 31,713 | - |
| 312 | INVA | Innoviva, Inc. | 1.52B | -0.71% | 1,188,091 | 440.00M |
| 313 | ARDT | Ardent Health, Inc. | 1.51B | -0.19% | 412,268 | 6.41B |
| 314 | AGL | agilon health, inc. | 1.50B | -0.55% | 186,715 | 5.92B |
| 315 | BCAX | Bicara Therapeutics Inc. | 1.49B | 2.68% | 491,967 | - |
| 316 | OMCL | Omnicell, Inc. | 1.49B | 0.59% | 394,284 | 1.25B |
| 317 | XERS | Xeris Biopharma Holdings, Inc. | 1.49B | 4.88% | 2,341,221 | 335.41M |
| 318 | AVLN | Avalyn Pharma Inc. | 1.48B | -3.69% | 317,013 | - |
| 319 | HCSG | Healthcare Services Group, Inc. | 1.47B | -1.83% | 697,755 | 1.86B |
| 320 | AZTA | Azenta, Inc. | 1.47B | 1.26% | 719,192 | 613.81M |
| 321 | NUTX | Nutex Health Inc. | 1.47B | -1.38% | 108,230 | 846.72M |
| 322 | INNV | InnovAge Holding Corp. | 1.46B | -1.38% | 187,739 | 989.71M |
| 323 | KMTS | Kestra Medical Technologies, Ltd. | 1.45B | 1.12% | 287,218 | 106.73M |
| 324 | DRTS | Alpha Tau Medical Ltd. | 1.43B | 2.99% | 858,879 | - |
| 325 | RARE | Ultragenyx Pharmaceutical Inc. | 1.43B | 12.58% | 12,427,775 | 717.00M |
| 326 | DMRA | Damora Therapeutics, Inc. | 1.41B | -7.13% | 605,292 | - |
| 327 | AAPG | Ascentage Pharma Group International | 1.40B | -0.19% | 3,163 | 94.61M |
| 328 | TRAX | First Tracks Biotherapeutics, Inc. | 1.40B | 0.51% | 554,757 | - |
| 329 | PAHC | Phibro Animal Health Corporation | 1.40B | -2.42% | 212,033 | 1.52B |
| 330 | AVBP | ArriVent BioPharma, Inc. | 1.40B | 2.60% | 456,427 | - |
| 331 | PNTG | The Pennant Group, Inc. | 1.40B | -5.77% | 1,386,584 | 1.10B |
| 332 | CNMD | CONMED Corporation | 1.38B | -1.93% | 307,092 | 1.37B |
| 333 | SVRA | Savara Inc. | 1.38B | 5.65% | 1,228,638 | - |
| 334 | CGEM | Cullinan Therapeutics, Inc. | 1.37B | 3.54% | 756,666 | - |
| 335 | LBRX | LB Pharmaceuticals Inc | 1.36B | -1.01% | 314,496 | - |
| 336 | AMN | AMN Healthcare Services, Inc. | 1.34B | -1.06% | 660,482 | 3.43B |
| 337 | OMER | Omeros Corporation | 1.34B | 6.40% | 2,496,460 | 38.42M |
| 338 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | 2.71% | 1,156,335 | - |
| 339 | CERT | Certara, Inc. | 1.31B | 5.54% | 2,181,562 | 421.75M |
| 340 | MAZE | Maze Therapeutics, Inc. | 1.30B | -2.01% | 363,522 | 20.00M |
| 341 | VOR | Vor Biopharma Inc. | 1.30B | -0.27% | 1,543,929 | - |
| 342 | AKTS | Aktis Oncology, Inc. | 1.27B | 0.66% | 500,877 | 10.06M |
| 343 | MGTX | MeiraGTx Holdings plc | 1.25B | 2.27% | 953,000 | 397.50M |
| 344 | CRON | Cronos Group Inc. | 1.24B | 2.43% | 747,916 | 179.09M |
| 345 | HROW | Harrow, Inc. | 1.24B | -3.16% | 874,699 | 275.59M |
| 346 | USPH | U.S. Physical Therapy, Inc. | 1.24B | -0.37% | 190,730 | 804.27M |
| 347 | ANRO | Alto Neuroscience, Inc. | 1.22B | 3.27% | 410,960 | - |
| 348 | OMDA | Omada Health, Inc. | 1.21B | 0.35% | 1,069,336 | 309.76M |
| 349 | REPL | Replimune Group, Inc. | 1.21B | -0.69% | 1,295,159 | - |
| 350 | OPK | OPKO Health, Inc. | 1.21B | 0.62% | 1,710,348 | 587.90M |
| 351 | IMTX | Immatics N.V. | 1.21B | 2.08% | 415,889 | 47.65M |
| 352 | TNDM | Tandem Diabetes Care, Inc. | 1.20B | -1.71% | 2,218,239 | 1.04B |
| 353 | IART | Integra LifeSciences Holdings Corporation | 1.17B | -5.98% | 1,051,329 | 1.65B |
| 354 | APMD | Apnimed, Inc. | 1.17B | 3.77% | 355,719 | 115.12M |
| 355 | SPTX | Seaport Therapeutics, Inc. | 1.17B | -1.45% | 205,613 | - |
| 356 | AORT | Artivion, Inc. | 1.16B | -4.56% | 572,579 | 471.47M |
| 357 | GDRX | GoodRx Holdings, Inc. | 1.16B | 0.29% | 781,304 | 785.23M |
| 358 | MNKD | MannKind Corporation | 1.15B | 0.85% | 2,733,344 | 393.63M |
| 359 | TDOC | Teladoc Health, Inc. | 1.14B | -2.33% | 2,539,652 | 2.49B |
| 360 | CSTL | Castle Biosciences, Inc. | 1.12B | 3.66% | 364,629 | 357.28M |
| 361 | PRCT | PROCEPT BioRobotics Corporation | 1.12B | 0.15% | 850,007 | 337.34M |
| 362 | ODTX | Odyssey Therapeutics, Inc. | 1.11B | 0.43% | 524,247 | 99.00K |
| 363 | LMRI | Lumexa Imaging Holdings, Inc. | 1.11B | -1.12% | 316,526 | 1.04B |
| 364 | JBIO | Jade Biosciences, Inc. | 1.09B | 2.94% | 815,835 | - |
| 365 | OBX | Obsidian Therapeutics, Inc. | 1.08B | 2.04% | 829,640 | - |
| 366 | GLUE | Monte Rosa Therapeutics, Inc. | 1.07B | -0.40% | 1,294,110 | 28.73M |
| 367 | SLBT | SL Science Holding Limited | 1.07B | 3.31% | 44,529 | 3.27M |
| 368 | STAA | STAAR Surgical Company | 1.07B | -5.22% | 786,718 | 339.59M |
| 369 | BVS | Bioventus Inc. | 1.06B | -4.32% | 385,731 | 581.85M |
| 370 | IRMD | IRADIMED CORPORATION | 1.06B | 0.19% | 90,972 | 86.34M |
| 371 | CRVS | Corvus Pharmaceuticals, Inc. | 1.06B | 2.62% | 1,534,754 | - |
| 372 | MLTX | MoonLake Immunotherapeutics | 1.05B | -0.88% | 2,298,118 | - |
| 373 | KURA | Kura Oncology, Inc. | 1.04B | 4.64% | 1,852,024 | 77.23M |
| 374 | ATTO | Attovia Therapeutics, Inc. | 1.04B | 2.16% | 292,606 | 1.80M |
| 375 | JANX | Janux Therapeutics, Inc. | 1.03B | 3.75% | 809,961 | 24.00M |
| 376 | ENOV | Enovis Corporation | 1.03B | -4.61% | 2,229,574 | 2.30B |
| 377 | HELP | Cybin Inc. | 1.02B | 4.08% | 3,344,325 | - |
| 378 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.01B | -0.54% | 465,638 | 730.02M |
| 379 | ALMS | Alumis Inc. | 1.01B | -1.51% | 3,515,368 | 7.40M |
| 380 | ABUS | Arbutus Biopharma Corporation | 1.00B | 0.40% | 2,714,961 | 181.72M |
| 381 | ANL | Adlai Nortye Group Ltd. | 984.00M | -1.55% | 91,495 | 18.06M |
| 382 | GMRS | GMR Solutions Inc. | 983.96M | -2.39% | 917,695 | 5.88B |
| 383 | SGP | SpyGlass Pharma, Inc. | 981.03M | 2.55% | 235,587 | - |
| 384 | PCRX | Pacira BioSciences, Inc. | 975.82M | -1.73% | 364,420 | 746.16M |
| 385 | BBNX | Beta Bionics, Inc. | 964.13M | -3.38% | 3,090,888 | 119.01M |
| 386 | CBLL | CeriBell, Inc. | 959.45M | 2.04% | 734,947 | 101.96M |
| 387 | SLDB | Solid Biosciences Inc. | 951.09M | 1.72% | 1,193,300 | - |
| 388 | SANA | Sana Biotechnology, Inc. | 928.02M | 6.16% | 2,916,202 | - |
| 389 | IMMX | Immix Biopharma, Inc. | 909.98M | 6.71% | 1,185,668 | - |
| 390 | FTH | Faeth Therapeutics, Inc. | 907.77M | 2.60% | 362,978 | - |
| 391 | LXRX | Lexicon Pharmaceuticals, Inc. | 905.49M | 0.74% | 2,235,725 | 41.47M |
| 392 | IVA | Inventiva S.A. | 899.28M | -1.06% | 1,811,255 | 7.94M |
| 393 | AVTX | Avalo Therapeutics, Inc. | 895.08M | 0.66% | 691,245 | 59.00K |
| 394 | HSTM | HealthStream, Inc. | 893.09M | -0.78% | 180,121 | 321.12M |
| 395 | TBPH | Theravance Biopharma, Inc. | 884.70M | 0.06% | 306,932 | 104.31M |
| 396 | WVE | Wave Life Sciences, Inc. | 874.89M | -1.44% | 2,171,817 | 65.37M |
| 397 | CADL | Candel Therapeutics, Inc. | 867.72M | 2.90% | 798,545 | - |
| 398 | OLMA | Olema Pharmaceuticals, Inc. | 866.23M | 1.75% | 927,406 | - |
| 399 | RIGL | Rigel Pharmaceuticals, Inc. | 856.47M | 3.08% | 165,707 | 276.79M |
| 400 | GERN | Geron Corporation | 848.06M | 2.33% | 9,819,461 | 204.56M |
| 401 | ARDX | Ardelyx, Inc. | 842.25M | -0.29% | 4,231,974 | 450.89M |
| 402 | INMD | InMode Ltd. | 835.77M | -0.27% | 413,626 | 374.63M |
| 403 | BLSM | BlossomHill Therapeutics, Inc. | 821.86M | 2.17% | 247,626 | - |
| 404 | AVR | Anteris Technologies Global Corp. | 820.60M | 0.60% | 444,982 | 2.24M |
| 405 | ACHV | Achieve Life Sciences, Inc. | 813.96M | 6.60% | 1,871,053 | - |
| 406 | FDMT | 4D Molecular Therapeutics, Inc. | 810.99M | 6.69% | 930,541 | 92.01M |
| 407 | SIBN | SI-BONE, Inc. | 808.53M | -2.70% | 595,338 | 213.60M |
| 408 | CLYM | Climb Bio, Inc. | 807.55M | -0.35% | 987,372 | - |
| 409 | DSGN | Design Therapeutics, Inc. | 801.67M | 2.40% | 601,179 | - |
| 410 | ACRS | Aclaris Therapeutics, Inc. | 794.87M | 1.50% | 3,822,970 | 8.22M |
| 411 | ANNX | Annexon, Inc. | 790.54M | 6.11% | 3,119,706 | - |
| 412 | VREX | Varex Imaging Corporation | 781.42M | 0.38% | 1,186,147 | 865.00M |
| 413 | AHCO | AdaptHealth Corp. | 768.44M | -2.54% | 2,458,138 | 3.36B |
| 414 | SLN | Silence Therapeutics plc | 764.66M | 1.60% | 690,466 | 615.00K |
| 415 | PHAR | Pharming Group N.V. | 762.39M | 1.70% | 5,400 | 366.48M |
| 416 | GYRE | Gyre Therapeutics, Inc. | 761.32M | 7.16% | 143,908 | 109.82M |
| 417 | QDEL | QuidelOrtho Corporation | 760.50M | 2.97% | 1,387,414 | 2.67B |
| 418 | DBVT | DBV Technologies S.A. | 754.91M | 6.53% | 158,768 | 5.04M |
| 419 | GLAS | Glass House Brands Inc. | 753.00M | -0.50% | 581,010 | 176.98M |
| 420 | COLL | Collegium Pharmaceutical, Inc. | 728.59M | 0.86% | 707,363 | 808.21M |
| 421 | SOPH | SOPHiA GENETICS SA | 726.14M | 6.89% | 1,211,215 | 86.17M |
| 422 | CBIO | Crescent Biopharma, Inc. | 717.77M | -2.39% | 665,895 | 11.88M |
| 423 | ZVRA | Zevra Therapeutics, Inc. | 703.10M | 0.34% | 1,591,440 | 136.07M |
| 424 | IRWD | Ironwood Pharmaceuticals, Inc. | 698.96M | 1.44% | 3,486,835 | 389.32M |
| 425 | NVCT | Nuvectis Pharma, Inc. | 696.59M | -2.24% | 240,802 | - |
| 426 | SGMT | Sagimet Biosciences Inc. | 694.31M | 6.79% | 1,019,048 | - |
| 427 | MNPR | Monopar Therapeutics Inc. | 689.34M | 1.23% | 206,598 | - |
| 428 | VSTM | Verastem, Inc. | 683.75M | 3.14% | 1,734,244 | 87.53M |
| 429 | MDXG | MiMedx Group, Inc. | 683.62M | -0.85% | 935,337 | 355.17M |
| 430 | AURA | Aura Biosciences, Inc. | 683.41M | -2.08% | 916,367 | - |
| 431 | CTKB | Cytek Biosciences, Inc. | 677.21M | 5.68% | 2,231,806 | 206.71M |
| 432 | STLN | Starling Oncology, Inc. | 675.70M | 1.53% | 3,218,849 | 587.24M |
| 433 | SSII | SS Innovations International, Inc. | 653.26M | -0.31% | 80,909 | 52.40M |
| 434 | NGNE | Neurogene Inc. | 648.57M | -6.52% | 171,523 | 925.00K |
| 435 | OABI | OmniAb, Inc. | 645.53M | 2.07% | 983,968 | 38.46M |
| 436 | AHG | Akso Health Group | 642.53M | 0.66% | 3,023 | 13.83M |
| 437 | PHR | Phreesia, Inc. | 638.09M | 0.39% | 602,299 | 507.79M |
| 438 | ANGO | AngioDynamics, Inc. | 635.28M | -0.58% | 520,945 | 320.17M |
| 439 | ALT | Altimmune, Inc. | 630.24M | - | 3,457,393 | 31.00K |
| 440 | MPLT | MapLight Therapeutics, Inc. | 629.12M | -0.70% | 545,817 | - |
| 441 | VALN | Valneva SE | 621.20M | 0.15% | 11,003 | 163.30M |
| 442 | OCS | Oculis Holding AG | 616.09M | 0.81% | 248,044 | 1.45M |
| 443 | PHAT | Phathom Pharmaceuticals, Inc. | 615.58M | 0.78% | 1,364,063 | 239.66M |
| 444 | CTMX | CytomX Therapeutics, Inc. | 614.48M | 1.99% | 4,214,978 | 18.30M |
| 445 | SCTX | Scribe Therapeutics Inc. | 608.46M | 10.45% | 303,841 | 33.30M |
| 446 | CRMD | CorMedix Inc. | 607.19M | -0.38% | 684,558 | 462.25M |
| 447 | DRUG | Bright Minds Biosciences Inc. | 602.76M | 4.13% | 67,351 | - |
| 448 | FLGT | Fulgent Genetics, Inc. | 601.21M | 1.02% | 311,990 | 323.93M |
| 449 | ALLO | Allogene Therapeutics, Inc. | 597.70M | 2.37% | 3,947,983 | 4.64M |
| 450 | AGMB | AgomAb Therapeutics NV | 594.92M | 5.87% | 339,332 | - |
| 451 | EVO | Evotec SE | 588.14M | 2.45% | 13,810 | 819.47M |
| 452 | STTK | Shattuck Labs, Inc. | 587.13M | -0.51% | 654,282 | 1.00M |
| 453 | WEAV | Weave Communications, Inc. | 586.39M | 0.14% | 1,342,755 | 257.79M |
| 454 | AQST | Aquestive Therapeutics, Inc. | 584.88M | -3.32% | 2,530,112 | 54.09M |
| 455 | KIDS | OrthoPediatrics Corp. | 568.67M | -5.92% | 305,588 | 252.72M |
| 456 | DCTH | Delcath Systems, Inc. | 563.86M | 0.18% | 437,166 | 95.42M |
| 457 | PRME | Prime Medicine, Inc. | 558.62M | 4.67% | 3,253,715 | 4.07M |
| 458 | EPRX | Eupraxia Pharmaceuticals Inc. | 551.11M | 3.58% | 257,765 | - |
| 459 | CAPR | Capricor Therapeutics, Inc. | 547.67M | 10.05% | 3,938,770 | 11.13M |
| 460 | PROK | ProKidney Corp. | 544.18M | -2.70% | 1,048,838 | 818.00K |
| 461 | BWAY | BrainsWay Ltd. | 543.39M | 0.52% | 32,567 | 60.70M |
| 462 | ARVN | Arvinas, Inc. | 543.36M | 1.84% | 533,103 | 316.70M |
| 463 | RGNX | REGENXBIO Inc. | 542.30M | 2.94% | 1,692,174 | 174.48M |
| 464 | TLRY | Tilray Brands, Inc. | 539.75M | 0.25% | 2,915,715 | 915.45M |
| 465 | CTEV | Claritev Corporation | 537.74M | -5.45% | 187,919 | 994.67M |
| 466 | CERS | Cerus Corporation | 536.06M | 5.14% | 2,463,531 | 221.55M |
| 467 | TECX | Tectonic Therapeutic, Inc. | 531.94M | -2.51% | 186,778 | - |
| 468 | EOLS | Evolus, Inc. | 529.06M | 0.25% | 1,223,330 | 316.49M |
| 469 | DNA | Ginkgo Bioworks Holdings, Inc. | 527.95M | 11.05% | 2,660,017 | 132.42M |
| 470 | OVID | Ovid Therapeutics Inc. | 527.30M | 0.75% | 1,985,776 | 1.58M |
| 471 | ENTX | Entera Bio Ltd. | 524.62M | 2.36% | 310,172 | 42.00K |
| 472 | INDP | Indaptus Therapeutics, Inc. | 523.64M | 22.43% | 920,856 | - |
| 473 | ASMB | Assembly Biosciences, Inc. | 515.94M | -0.55% | 364,770 | 74.85M |
| 474 | TCMD | Tactile Systems Technology, Inc. | 511.04M | 1.76% | 634,735 | 350.31M |
| 475 | AUTL | Autolus Therapeutics plc | 511.03M | 2.67% | 1,091,190 | 117.39M |
| 476 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 477 | KMDA | Kamada Ltd. | 501.36M | 5.86% | 140,717 | 191.85M |
| 478 | SENS | Senseonics Holdings, Inc. | 498.60M | 4.08% | 990,860 | 48.55M |
| 479 | CTNM | Contineum Therapeutics, Inc. | 496.98M | -4.00% | 580,101 | - |
| 480 | PBYI | Puma Biotechnology, Inc. | 491.42M | 1.38% | 206,101 | 231.24M |
| 481 | NPCE | NeuroPace, Inc. | 485.69M | 0.35% | 108,078 | 106.99M |
| 482 | ARCT | Arcturus Therapeutics Holdings Inc. | 481.20M | 8.53% | 1,302,455 | 29.37M |
| 483 | SRTA | Strata Critical Medical, Inc. | 475.95M | 3.07% | 571,515 | 255.98M |
| 484 | VOGX | Vogenx, Inc. | 475.01M | 2.22% | 209,757 | - |
| 485 | PRLD | Prelude Therapeutics Incorporated | 470.69M | 2.24% | 533,876 | 22.42M |
| 486 | EIKN | Eikon Therapeutics, Inc. | 465.82M | 1.06% | 640,256 | - |
| 487 | NRC | NRC Health | 461.64M | -5.35% | 88,125 | 140.00M |
| 488 | MASS | 908 Devices Inc. | 453.84M | 10.69% | 689,783 | 60.84M |
| 489 | RLMD | Relmada Therapeutics, Inc. | 448.01M | -0.47% | 772,868 | - |
| 490 | SGHT | Sight Sciences, Inc. | 445.11M | -0.74% | 201,334 | 83.38M |
| 491 | IRD | Opus Genetics, Inc. | 439.27M | -2.40% | 1,531,534 | 9.86M |
| 492 | ZURA | Zura Bio Limited | 437.94M | -0.87% | 1,668,360 | - |
| 493 | CABA | Cabaletta Bio, Inc. | 437.43M | 3.61% | 4,258,044 | - |
| 494 | KYTX | Kyverna Therapeutics, Inc. | 435.38M | 2.03% | 530,753 | - |
| 495 | PRTA | Prothena Corporation plc | 434.31M | 2.67% | 404,758 | 54.53M |
| 496 | PACB | Pacific Biosciences of California, Inc. | 428.95M | 2.99% | 6,228,857 | 159.27M |
| 497 | AVIR | Atea Pharmaceuticals, Inc. | 421.88M | 2.14% | 279,428 | - |
| 498 | CARL | Carlsmed, Inc. | 420.19M | 0.52% | 73,864 | 63.30M |
| 499 | CCCC | C4 Therapeutics, Inc. | 420.13M | -1.01% | 1,758,173 | 35.04M |
| 500 | CLPT | ClearPoint Neuro, Inc. | 419.13M | 2.54% | 477,517 | 42.28M |